TherapeuticsMD (TXMD) Interest Coverage Ratio Growth (1y) (2011 - 2025)
TherapeuticsMD (TXMD) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -21.30% |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 23.99% |
| Jun 30, 2025 | 37.70% |
| Sep 30, 2024 | -326.40% |
| Jun 30, 2024 | -915.41% |
| Mar 31, 2023 | -4,200.62% |
| Mar 31, 2022 | 56.68% |
| Dec 31, 2021 | 3.67% |
| Sep 30, 2021 | -99.46% |
| Jun 30, 2021 | 27.74% |
| Mar 31, 2021 | 64.80% |
| Dec 31, 2020 | 13.07% |
| Sep 30, 2020 | 23.22% |
| Jun 30, 2020 | 37.99% |
| Mar 31, 2020 | 55.40% |
| Dec 31, 2019 | 56.96% |
| Sep 30, 2019 | 71.11% |
| Jun 30, 2019 | 83.37% |
| Mar 31, 2013 | 84.93% |
| Dec 31, 2012 | 92.92% |
| Sep 30, 2012 | 47.03% |